world-hematology-nursing-care-2019-scientifictracks

7 / 15

Page 20
Volume 2
July 24-25, 2019 | Rome, Italy
World Hematology 2019 & Nursing Care 2019
July 24-25, 2019
Journal of Blood Disorders and Treatment
47th WORLD CONGRESS ON NURSING CARE
11th WORLD HEMATOLOGY AND ONCOLOGY CONGRESS
&
J Blood Disord Treat, Volume 2
The link between breast cancer and hypercoagulability
Janette Bester, Julien Nunes Concalves
University of Pretoria, RSA
Statement of the Problem: Breast cancer patients are at an increased
risk for thrombotic events such as deep vein thrombosis (DVT) and
venous thromboembolism (VTE), drastically affecting survival and
quality of life post-treatment for these patients. It has been proposed
that this increased risk is caused by cancer associated inflammation-
induced hypercoagulation, a key factor involved in thrombus
formation.
Methodology & Theoretical Orientation: This study utilized
microscopy and rheological techniques to examine coagulation
components during clot formation, in order to obtain a better understanding of how changes to these components may increase
thrombus formation and thus the risk of thrombotic events. Whole blood from treatment-naïve breast cancer patients were
compared to whole blood from healthy controls. Routine clinical tests were used to obtain an overall clinical picture of
each participant. Scanning electron microscopy was used to study the fine ultrastructure of the red blood cells and platelets.
Thromboelastography (TEG) was used to study the changes in clot dynamics during coagulation.
Findings: SEM showed platelets to be activated as well as a presence of spontaneous fibrin fibre formation. Also, red blood
cells from the patient group showed more irregular surface membranes, increased agglutination and eryptosis when compared
to healthy controls. Results from the TEG showed that clots form faster in breast cancer patients, with increased strength and
rigidity, thus revealing the hypercoagulable nature of whole blood in this patient group. The results in this study have revealed
the marked differences in coagulation and associated blood components between healthy controls and treatment-naïve breast
cancer patients.
Conclusion & Significance: They provide a greater understanding of clot formation dynamics and has shown that even in a
small sample size, breast cancer patients are at an increased risk of thrombotic events, traceable through rheological techniques.
This justifies further investigation into the utilization of these techniques in a clinical, point-of-care setting, in order to increase
the chance of survival and quality of life for these patient’s post-treatment.
Biography
Janette Bester has been establishing her research group as well as her research focus since 2015. Her research focusses mainly
on vascular complications, specifically hemorheology in chronic inflammatory diseases such as Type 2 Diabetes, breast cancer and
prostate cancer patients. She uses novel techniques that distinguishes her from most of the research in her field. Her goal with her
research is to improve tissue perfusion to improve wound healing as well as quality of life in patients with vascular complications as
well as to determine the thrombotic risk in a specific patient population.
Scanning electron images of whole blood. A: Healthy control group
images showing normal red blood cells B: Breast cancer group
images showing abnormal deformed red blood cells. Scale: 1µm